Johnson & Johnson Will Break Itself Up Into Two Companiesnews2021-11-12T22:49:01+00:00November 12th, 2021|The New York Times|
Biden Chooses Robert Califf to Lead F.D.A., Despite Drug Industry Tiesnews2021-11-12T21:31:34+00:00November 12th, 2021|The New York Times|
Antony Blinken Says ‘We Have Fallen Short’ on Global Vaccine Distributionnews2021-11-10T18:28:19+00:00November 10th, 2021|The New York Times|
Oklahoma Supreme Court Throws Out $465 Million Opioid Ruling Against J.&J.news2021-11-10T05:03:51+00:00November 10th, 2021|The New York Times|
Moderna and U.S. at Odds Over Vaccine Patent Rightsnews2021-11-10T00:23:03+00:00November 10th, 2021|The New York Times|
Democrats Choosing Less Risky Path on Drug Pricesnews2021-11-06T07:00:07+00:00November 6th, 2021|The New York Times|
House Passes $1 Trillion Infrastructure Bill, Putting Social Policy Bill on Holdnews2021-11-06T04:58:33+00:00November 6th, 2021|The New York Times|
Pfizer Says Its Antiviral Pill Is Highly Effective in Treating Covidnews2021-11-05T19:13:46+00:00November 5th, 2021|The New York Times|
Elizabeth Holmes Trial Exposes Investors’ Lack of Due Diligencenews2021-11-04T20:14:14+00:00November 4th, 2021|The New York Times|
U.K. Authorizes Merck’s Antiviral Pill for Covid-19news2021-11-04T17:42:59+00:00November 4th, 2021|The New York Times|